CLINICAL_TRIALS
trial_result
· 2025-10-31
Clinical Trial Update: Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059) [Phase 3]
Summary
Phase 3 pediatric study of ertugliflozin for Type 2 Diabetes Mellitus has completed, and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2025-10-31